Nexium Approved for Prevention of GU and DU in Patients Receiving Low-Dose Aspirin: Daiichi Sankyo, AZ

Daiichi Sankyo and AstraZeneca K.K. (AZ) announced on June 22 that AZ obtained on the same day an approval for the proton pump inhibitor (PPI) Nexium (esomeprazole magnesium) for the prevention of recurrence of gastric ulcer (GU) and duodenal ulcer...read more